Related references
Note: Only part of the references are listed.SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Annika Nelde et al.
NATURE IMMUNOLOGY (2021)
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette et al.
CELL (2021)
Genetic Variants of SARS-CoV-2-What Do They Mean?
Adam S. Lauring et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Optimism and caution for an inactivated COVID-19 vaccine
Christina A. Rostad et al.
LANCET INFECTIOUS DISEASES (2021)
Looking beyond COVID-19 vaccine phase 3 trials
Jerome H. Kim et al.
NATURE MEDICINE (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses
Young Min Son et al.
SCIENCE IMMUNOLOGY (2021)
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Elizabeth M. Anderson et al.
CELL (2021)
Nucleic Acid-Based Technologies Targeting Coronaviruses
Thi Khanh Le et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4+ T Cells in the Pathogenesis of HIV-2 Infection and Disease Progression
Sivasankaran Munusamy Ponnan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Ebola virus disease: current vaccine solutions
Oyewale Tomori et al.
CURRENT OPINION IN IMMUNOLOGY (2021)
Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins
Sara Morsy et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2021)
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin
Pragya D. Yadav et al.
JOURNAL OF TRAVEL MEDICINE (2021)
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells
Isabel Schulien et al.
NATURE MEDICINE (2021)
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost in healthy UK adults
Morven Wilkie et al.
VACCINE (2020)
NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential
Pasqualina De Leo et al.
CLINICAL IMMUNOLOGY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
The Challenges of Vaccine Development against a New Virus during a Pandemic
Michael S. Diamond et al.
CELL HOST & MICROBE (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Zhenming Jin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Prevalence of Asymptomatic SARS-CoV-2 Infection A Narrative Review
Daniel P. Oran et al.
ANNALS OF INTERNAL MEDICINE (2020)
On the molecular determinants of the SARS-CoV-2 attack
Darja Kanduc et al.
CLINICAL IMMUNOLOGY (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
Comprehensive mapping of immune perturbations associated with severe COVID-19
Leticia Kuri-Cervantes et al.
SCIENCE IMMUNOLOGY (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Clinical and pathological investigation of patients with severe COVID-19
Shaohua Li et al.
JCI INSIGHT (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
Malika Aid et al.
CELL (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Controlling the SARS-CoV-2 spike glycoprotein conformation
Rory Henderson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients
Anna E. Oja et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Jose Mateus et al.
SCIENCE (2020)
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine
Darja Kanduc et al.
IMMUNOLOGIC RESEARCH (2020)
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
Coraline Radermecker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng et al.
NATURE IMMUNOLOGY (2020)
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing et al.
NATURE MEDICINE (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Ellen Shrock et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Paving the Road for RNA Therapeutics
Niels Dammes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
Phuong Nguyen-Contant et al.
MBIO (2020)
Recombinant vaccines for COVID-19
Tushar Yadav et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Inactivated COVID-19 vaccines to make a global impact
Patrick L. Iversen et al.
LANCET INFECTIOUS DISEASES (2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Kevin W. Ng et al.
SCIENCE (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
Bernadette Schurink et al.
LANCET MICROBE (2020)
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Mehul S. Suthar et al.
CELL REPORTS MEDICINE (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Baweleta Isho et al.
SCIENCE IMMUNOLOGY (2020)
Double-Stranded RNA Sensors and Modulators in Innate Immunity
Sun Hur
Annual Review of Immunology (2019)
Bispecific Antibody (bsAb) Construct Formats and their Application in Cancer Therapy
Desmond O. Achcampong
PROTEIN AND PEPTIDE LETTERS (2019)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
Shane Crotty
IMMUNITY (2019)
Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study
Muhammad Tahir Ul Qamar et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Advances in mRNA Vaccines for Infectious Diseases
Cuiling Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Novel viral vectors in infectious diseases
Ian R. Humphreys et al.
IMMUNOLOGY (2018)
Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines
Hassan Elsayed et al.
JOURNAL OF VIROLOGY (2018)
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
Annette B. Vogel et al.
MOLECULAR THERAPY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India
Sivasankaran Munusamy Ponnan et al.
PLOS ONE (2018)
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
Harm HogenEsch et al.
NPJ VACCINES (2018)
A Novel Fusion Antibody Exhibits Antiangiogenic Activity and Stimulates NK Cell-mediated Immune Surveillance Through Fused NKG2D Ligand
Desmond O. Acheampong et al.
JOURNAL OF IMMUNOTHERAPY (2017)
A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
Chao Shan et al.
NATURE MEDICINE (2017)
Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy
Desmond O. Acheampong et al.
PROTEIN AND PEPTIDE LETTERS (2017)
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Katie Ewer et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
Johannes Lutz et al.
NPJ VACCINES (2017)
A human IgG-like bispecific antibody co-targeting epidermal growth factor receptor and the vascular endothelial growth factor receptor 2 for enhanced antitumor activity
Zhiguo Chen et al.
CANCER BIOLOGY & THERAPY (2016)
B Cells, Antibodies, and More
William Hoffman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide
Darja Kanduc et al.
AUTOIMMUNITY REVIEWS (2016)
A novel bispecific diabody targeting both vascular endothelial growth factor receptor 2 and epidermal growth factor receptor for enhanced antitumor activity
Menghuai Xu et al.
BIOTECHNOLOGY PROGRESS (2016)
Precision medicine, genomics and drug discovery
Lon R. Cardon et al.
HUMAN MOLECULAR GENETICS (2016)
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Jincun Zhao et al.
IMMUNITY (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Mucosal adjuvants: Opportunities and challenges
Lingbin Zeng
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
Sam Afkhami et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
The Chemokine System in Innate Immunity
Caroline L. Sokol et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
RNA-Based Vaccines in Cancer Immunotherapy
Megan A. McNamara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
A brief history of T cell help to B cells
Shane Crotty
NATURE REVIEWS IMMUNOLOGY (2015)
A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
Fiona Smaill et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
Brian J. Laidlaw et al.
PLOS PATHOGENS (2013)
Development of a new hydrogen peroxide-based vaccine platform
Ian J. Amanna et al.
NATURE MEDICINE (2012)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Pathogen Recognition by the Innate Immune System
Himanshu Kumar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2h study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2011)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection
Jun Chen et al.
JOURNAL OF VIROLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Proinflammatory T helper type 17 cells are effective B-cell helpers
Meike Mitsdoerffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB
Shannon S. Martin et al.
VACCINE (2010)
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
J. E. Ledgerwood et al.
VACCINE (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring
Claudia Vellozzi et al.
VACCINE (2009)
Correlates of vaccine-induced immunity
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2008)
Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns
Burton A. Waisbren
MEDICAL HYPOTHESES (2008)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Roberto Baccala et al.
NATURE MEDICINE (2007)
Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
Elaine M. Castilow et al.
IMMUNOLOGIC RESEARCH (2007)
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus
SR Weiss et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection
TR Johnson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza
JM Wood et al.
NATURE REVIEWS MICROBIOLOGY (2004)
In vitro inactivation of the rabies virus by ascorbic acid
SN Madhusudana et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2004)
Reverse vaccinology: a genome-based approach for vaccine development
V Masignani et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2002)
Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity
FA Osorio et al.
VIROLOGY (2002)
Chemokine receptors: Multifaceted therapeutic targets
AEI Proudfoot
NATURE REVIEWS IMMUNOLOGY (2002)
Dendritic cell lineage, plasticity and cross-regulation
YJ Liu et al.
NATURE IMMUNOLOGY (2001)
Generation and maintenance of memory T cells
J Sprent et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Impact of genomics on drug discovery and clinical medicine
G Emilien et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2000)
A novel transcription factor, T-bet, directs Th1 lineage commitment
SJ Szabo et al.
CELL (2000)
The promise of nucleic acid vaccines
NP Restifo et al.
GENE THERAPY (2000)
Share Paper
